Table 6.
Analysis of factors influencing the prognosis of patients infected with 2019-nCoV
| Factors | Discharged (n=76) | Acute exacerbation (n=10) |
p |
|---|---|---|---|
| Gender | 27 | 8 | 0.013 |
| Male | 27 | 8 | |
| Female | 49 | 2 | |
| Age | |||
| < 65 | 52 | 3 | 0.031 |
| ≥ 65 | 24 | 7 | |
| Disease severity | |||
| Mild | 46 | 1 | <0.001 |
| Severe | 30 | 1 | |
| Critically ill | 0 | 8 | |
| BMI | |||
| <18.5 | 2 | 1 | 0.058 |
| 18.5-24 | 30 | 2 | |
| >24 | 42 | 1 | |
| Any comorbidity | |||
| Yes | 33 | 7 | 0.014 |
| No | 33 | 0 | |
| Glucocorticoid use | |||
| Yes | 26 | 6 | 0.164 |
| No | 50 | 4 | |
| WBC count (×109/L) | |||
| <3.5 | 9 | 1 | 0.820 |
| 3.5-9.5 | 62 | 6 | |
| >9.5 | 5 | 1 | |
| Lymphocyte count (×109/L) | |||
| <1.1 | 35 | 7 | 0.057 |
| 1.1-3.2 | 41 | 1 | |
| Eosinophil count (×109/L) | |||
| <0.02 | 36 | 6 | 0.151 |
| 0.02-0.52 | 39 | 1 | |
| >0.52 | 1 | 0 | |
| Monocyte count (×109/L) | |||
| 0.1-0.6 | 62 | 6 | 0.644 |
| >0.6 | 14 | 2 | |
| CRP (mg/L) | |||
| <1.0 | 10 | 1 | >0.990 |
| ≥1.0 | 66 | 7 | |
| ALT (U/L) | |||
| <33 | 50 | 6 | >0.990 |
| ≥33 | 25 | 2 | |
| AST (U/L) | |||
| <32 | 51 | 0 | <0.001 |
| ≥32 | 24 | 8 | |
| Globulin (g/L) | |||
| 20-35 | 59 | 6 | >0.990 |
| >35 | 16 | 2 | |
| LDH (U/L) | |||
| <214 | 37 | 0 | 0.008 |
| ≥214 | 38 | 8 | |
| Ferritin (ng/ml) | |||
| <150 | 14 | 0 | 0.319 |
| ≥150 | 38 | 5 | |
| IL-1β (pg/ml) | |||
| <5.0 | 47 | 6 | 0.548 |
| ≥5.0 | 5 | 1 | |
| IL-6 (pg/ml) | |||
| <7.0 | 41 | 1 | 0.005 |
| ≥7.0 | 11 | 5 | |
| IL-2R (U/ml) | |||
| <223 | 12 | 1 | <0.001 |
| 223-710 | 37 | 0 | |
| >710 | 3 | 6 | |
| IL-8 (pg/ml) | |||
| <62 | 50 | 4 | 0.010 |
| ≥62 | 2 | 3 | |
| IL-10 (pg/ml) | |||
| <9.1 | 48 | 4 | 0.053 |
| ≥9.1 | 2 | 2 | |
| TNF-α (pg/ml) | |||
| <8.1 | 41 | 3 | 0.051 |
| ≥8.1 | 10 | 4 | |
| D-dimer (μg/ml) | |||
| <0.5 | 39 | 1 | 0.027 |
| ≥0.5 | 31 | 7 | |
| PT (s) | |||
| <14.5 | 49 | 3 | 0.104 |
| ≥14.5 | 20 | 5 | |
| cTnI (μg/L) | |||
| <15.6 | 48 | 3 | 0.019 |
| ≥15.6 | 4 | 3 |